Monday, November 30, 2020

No-Size-Fits-All; How Venture Capital Firms like SprintVC are Closing in on Industry Niches

What comes to mind when most people think of Venture Capital (VC) firms? A lot of the time, it is the institutional approval and...
More

    Latest Posts

    You are Never too Young to go in Search of your Dreams: Javed Khan, an Entrepreneur of only 22 years old is the Proof...

    From a very early age, we all have dreams that we lose along the way for various reasons. One of the most frequent is...

    Arnold Onyegbutulem Talks About Key Qualities Successful Project Managers Have in Common

    Being a purpose- driven and result-oriented kind of person, I pay attention to the stories of successful people. What they did, how they did...

    How to Use Press Releases for Branding, Online Reputation Management, SEO and Traffic

    More details about our services can be found at: https://pressrelease.network In this video, we are talking about the benefits, of Press Release Distribution. So, why do...

    Introducing PressRelease.Network, Our Press Release Publishing & Distribution Service

    In this video, we are talking about the benefits, of Press Release Distribution. So, why do you need to send out a press release? Well,...

    ZingiVir-H Covid-19 Tablets – Keralam Brings Ayurvedic Medicine For Treatment and Prevention of Coronavirus

    ZingiVir-H Tab is a Herbo-mineral tablet that is a blend of 7 ingredients. It is scientifically proven for its antipyretic, anti-inflammatory, and anti-bronchitis activities.

    The trial data of ZingiVir-H can be found at: http://ctri.nic.in/Clinicaltrials/pdf_generate.php?trialid=43168&EncHid=&modid=&compid=%27,%2743168det%27

    With the number of people infected by COVID-19 just under 2 million in India, Pankajakasthuri Herbals India Private Limited (PKHIL) announced significant success in their study to find a treatment for the novel coronavirus patients.

    The company released the successful completion of the clinical trials for its tablet, ZingiVir-H as an add-on therapy for the pandemic. The clinical trials were conducted on 116 patients infected by COVID-19 at medical colleges across the country, with 58 being administered Zingivir-H and the rest given a placebo. The studies found that 58 patients treated with the herbo-mineral drug, ZingiVir–H recovered and reported a negative Reverse Transcription Polymerase Chain Reaction (RT-PCR) recovery in an average of 5 days while others took an average of 8 days to recover. The clinical trials of ZingiVir–H have been completed following the guidelines provided by the World Health Organization and the final results have been submitted to the Ministry of Ayurveda, Yoga & Naturopathy, Unani, Siddha and Homoeopathy (AYUSH) for approval.

    Talking about the completion of the clinical trials, Padma Shri Dr. J Hareendran Nair, Founder and MD of PKHIL and Pankajakasthuri Herbal Research Foundation said, “It gives me immense pride and honour to announce that our medication, ZingiVir –H, has been successful in providing much-needed assistance and help to COVID-19 patients in their recovery. I would like to commend my team who have rigorously helped me with the clinical trials and associated studies. This is one of the first herbo-mineral drug and ayurvedic that has achieved a negative RT PCR test as a primary endpoint.”

    The clinical studies took place at KR Hospital, Mysuru, Karnataka; RCSM Medical College and CPR Hospital, Kolhapur, Maharashtra; Saveetha Medical College and Hospital, Chennai, Tamil Nadu and ESIC Medical College and Hospital, Faridabad, Haryana. “We wanted to test the efficacy of the drug, which is made with seven ingredients, on patients in various hospitals across the country. This has further encouraged us and strengthened our belief that Ayurveda-based drugs can play a vital role in this fight against COVID-19. We are also soon planning to announce the results of the ongoing clinical trial with standalone treatment on 135 patients,” Dr. Nair added.

    Commenting on the Ministry of AYUSH to expedite the process of necessary approvals for all the Ayurveda drugs that are undergoing clinical trials in various hospitals in the country Dr. Nair said, “Today, when millions of people suffering from this harmful disease and are in hospitals battling the virus, I would like to urge the Ministry of AYUSH to support scientifically backed modern Ayurveda-based treatments and drugs that have long-lasting benefits and can help save lives. At PKHIL, we are equipped to scale up and meet the requirements of the nation, once necessary approvals are issued by the ministry.”

    Pankajakasthuri Herbals India Pvt. Ltd. submitted the first reports of ZingiVir-H to Ministry of AYUSH at the end of June 2020, while the interim report of 42 patients examined by a peer review committee was submitted on July 8th and the primary endpoint result of 116 patients was submitted to on July 24th. The company is expecting the final decision from the ministry soon.

    Possible side effects / Adverse effects

    Due to the absence of any harsh chemicals, there are no adverse drug reactions expected.

    This news post is tagged with , , , , , , ,

    Latest Posts

    No-Size-Fits-All; How Venture Capital Firms like SprintVC are Closing in on Industry Niches

    What comes to mind when most people think of Venture Capital (VC) firms? A lot of the time, it is the institutional approval and...

    You are Never too Young to go in Search of your Dreams: Javed Khan, an Entrepreneur of only 22 years old is the Proof...

    From a very early age, we all have dreams that we lose along the way for various reasons. One of the most frequent is...

    Arnold Onyegbutulem Talks About Key Qualities Successful Project Managers Have in Common

    Being a purpose- driven and result-oriented kind of person, I pay attention to the stories of successful people. What they did, how they did...

    How to Use Press Releases for Branding, Online Reputation Management, SEO and Traffic

    More details about our services can be found at: https://pressrelease.network In this video, we are talking about the benefits, of Press Release Distribution. So, why do...

    Don't Miss

    Tiny Robots To Teach Children, Educational Company Launches mTiny Robot

    Tiny Robots To Teach Children, Educational Company Launches mTiny Robot   The global provider of educational solutions STEAM Makeblock today launches its new product. It is...

    Advantages of Running a Completely Remote Digital Business

    Where flexibility at work can be a biggest asset for any employee, why wouldn’t there be immense attraction? Companies providing flexibility in the form of...

    To Help Save The Jobs Affected By Automation Twitter CEO Jack Dorsey Pledges $5 Million to Andrew Yang’s Humanity Forward

    In an effort to support he former presidential candidate Andrew Yang’s universal basic income and COVID-19 relief efforts, witter and Square CEO Jack Dorsey donates 5 million dollars to the Humanity Forward nonprofit organization, reports The Verge.

    Supreme Court Of India Lifts Cryptocurrency Ban, Quashes RBI’s Complete Ban And Allows Trading

    Big day for blockchain enthusiasts and cryptocurrency entrepreneurs in India. In a massive verdict, The Supreme Court of India has lifted the 'crypto currency or other digital assets trading ban' imposed by Reserve Bank Of India in 2018.

    Jason Kulpa Comments on the Do’s and Don’ts of Managing Net Worth in a Volatile Market

    Jason Kulpa Comments on the Do's and Don'ts of Managing Net Worth in a Volatile Market As the global market heads for choppy waters, investors,...

    Stay in touch

    To be updated with all the latest news, offers and special announcements.